| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |